Grid Biosciences
Hong Kong - New TerritoriesBiotechnology
Focus: Grid Biosciences is a Hong Kong-based biotech company focused on vaccine development in infectious diseases. Limited public data suggests an early-stage operation with a lean footprint.
Profile data last refreshed 43m ago · AI intelligence enriched 1w ago
Open Jobs
6-5 this month
Cooling — net -5 jobs in 30d
7 added, 12 removed. Slower than typical.
Should You Work at Grid Biosciences?
AI assessmentGrid Biosciences is a speculative early-stage vaccine biotech with opaque development status; only pursue if seeking hands-on pre-revenue work in infectious diseases with high uncertainty tolerance.
Why Work Here
- Opportunity to build vaccine programs from the ground up in a growing infectious disease space
- Lean organization (10 active roles) suggests flat structure and direct impact on early-stage R&D
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Grid Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.